Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
36.06
+0.59 (1.66%)
At close: Jun 2, 2026
SHA:688163 Market Cap
SHA:688163 has a market cap or net worth of 3.9 billion as of June 2, 2026. Its market cap has increased by 107.12% in one year.
Market Cap
3.90B
Enterprise Value
3.14B
Revenue
197.68M
Ranking
n/a
PE Ratio
67.34
Stock Price
36.06
Market Cap Chart
Since March 11, 2022, SHA:688163's market cap has decreased from 5.98B to 3.90B, a decrease of -34.79%. That is a compound annual growth rate of -9.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 3.90B | 65.64% |
| Dec 31, 2025 | 2.36B | 23.97% |
| Dec 31, 2024 | 1.90B | -12.16% |
| Dec 29, 2023 | 2.16B | -5.22% |
| Dec 30, 2022 | 2.28B | -61.86% |
| Mar 11, 2022 | 5.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Assure Tech (Hangzhou) | 4.26B |
| Wuhan Hvsen Biotechnology | 4.19B |
| Kexing Biopharm | 4.18B |
| Beijing Bohui Innovation Biotechnology Group | 4.16B |
| Beijing Scitop Bio-tech | 4.16B |
| Hinova Pharmaceuticals | 3.97B |
| Shanghai Obio Technology (Group) Corp. | 3.83B |
| Boji Medical Technology | 3.83B |